Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000631945 | SCV000753048 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2022-03-26 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 527166). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with FBN1-related conditions. This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 918 of the FBN1 protein (p.Pro918Ser). This variant is not present in population databases (gnomAD no frequency). |
ARUP Laboratories, |
RCV003736865 | SCV004562536 | uncertain significance | not provided | 2023-09-07 | criteria provided, single submitter | clinical testing |